Palisade Bio Inc (PALI)
6.30
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.30
0.00 (0.00%)
After-Hours: 20:00
Palisade Bio Cash from Operations (Quarterly): -3.18M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.18M |
| December 31, 2023 | -2.746M |
| September 30, 2023 | -2.662M |
| June 30, 2023 | -2.199M |
| March 31, 2023 | -3.526M |
| December 31, 2022 | -3.306M |
| September 30, 2022 | -3.04M |
| Date | Value |
|---|---|
| June 30, 2022 | -3.25M |
| March 31, 2022 | -3.764M |
| December 31, 2021 | -3.055M |
| September 30, 2021 | -2.746M |
| June 30, 2021 | -7.722M |
| March 31, 2021 | -1.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.722M
Minimum
Jun 2021
-1.25M
Maximum
Mar 2021
-3.265M
Average
-3.055M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| TG Therapeutics Inc | -8.207M |
| Protagenic Therapeutics Inc | -1.144M |
| Bio-Path Holdings Inc | -1.814M |
| Jaguar Health Inc | -7.047M |
| Finch Therapeutics Group Inc | -4.362M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 2.024M |
| Free Cash Flow | -10.79M |
| Free Cash Flow Per Share (Quarterly) | -4.140 |
| Free Cash Flow Yield | -294.5% |